After its giant mergers have tended to disappoint investors, Pfizer (PFE +3.1%) starts looking...

|About: Pfizer Inc. (PFE)|By:, SA News Editor

After its giant mergers have tended to disappoint investors, Pfizer (PFE +3.1%) starts looking the other direction - with plans to spin off big businesses like its consumer health and generic-drug units, Sanford Bernstein says after talking to the CEO. The deals could contract the revenue base 40%, but focus the company by shedding underperformers.